Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab183333-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$189.90
|
|
|
Ab183333-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$919.90
|
|
|
Ab183333-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,299.90
|
|
|
Ab183333-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$3,679.90
|
|
Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
| Product Name | Enapotamab vedotin (anti-Axl) - Primary antibody, specific to AXL, >90% (SDS-PAGE&SEC), high purity, Human IgG1, INHIBITOR of Tubulin inhibitor |
|---|---|
| Synonyms | Adhesion related kinase antibody | AI323647 antibody | Ark antibody | Axl antibody | AXL oncogene antibody | AXL receptor tyrosine kinase antibody | AXL transforming gene antibody | AXL transforming sequence/gene antibody | EC 2.7.10.1 antibody | JTK11 an |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥90%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | AXL |
| Conjugation | MC-VC-PAB-MMAE |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | INHIBITOR |
| Mechanism of action | INHIBITOR of Tubulin inhibitor |
| Product Description |
Enapotamab vedotin (anti-Axl) is an AXL-specific human IgG1 antibody conjugated to the microtubule disrupting agent monomethyl auristatin E (MMAE) through a protease cleavable valine-citrulline (vc) linker. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 150.63 kDa |
| Purification Method | Protein A purified |
| Purity | >90% (SDS-PAGE&SEC) |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 1912424-97-5 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Enapotamab vedotin (anti-Axl) (Ab183333) - Flow Cytometry
Flow Cytometry analysis of HeLa cells labelling Axl (red) with Enapotamab vedotin (anti-Axl) (Ab183333) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Enapotamab vedotin (anti-Axl) (Ab183333) - Flow Cytometry
Flow Cytometry analysis of U-2 OS cells labelling Axl (red) with Enapotamab vedotin (anti-Axl) (Ab183333) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Enapotamab vedotin (anti-Axl) (Ab183333) - ELISA
Immobilized Recombinant Human Axl protein (rp183600) at 1.0 μg/mL can bind Enapotamab vedotin (anti-Axl) (Ab183333) with the EC₅₀ of 28.23 ng/mL.
Enapotamab vedotin (anti-Axl) (Ab183333) - SEC
The purity of Enapotamab vedotin (anti-Axl) (Ab183333) is more than 95% verified by HPLC.